BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18019020)

  • 21. Active cigarette smoking and the risk of breast cancer at the level of N-acetyltransferase 2 (NAT2) gene polymorphisms.
    Kasajova P; Holubekova V; Mendelova A; Lasabova Z; Zubor P; Kudela E; Biskupska-Bodova K; Danko J
    Tumour Biol; 2016 Jun; 37(6):7929-37. PubMed ID: 26700672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic polymorphisms of phase I and phase II metabolic enzymes as modulators of lung cancer susceptibility.
    Mota P; Silva HC; Soares MJ; Pego A; Loureiro M; Cordeiro CR; Regateiro FJ
    J Cancer Res Clin Oncol; 2015 May; 141(5):851-60. PubMed ID: 25388590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of
    Walia HK; Singh N; Sharma S
    Pharmacogenomics; 2022 Jan; 23(2):97-118. PubMed ID: 34911343
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption.
    Lilla C; Verla-Tebit E; Risch A; Jäger B; Hoffmeister M; Brenner H; Chang-Claude J
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):99-107. PubMed ID: 16434594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.
    García-Closas M; Malats N; Silverman D; Dosemeci M; Kogevinas M; Hein DW; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Castaño-Vinyals G; Yeager M; Welch R; Chanock S; Chatterjee N; Wacholder S; Samanic C; Torà M; Fernández F; Real FX; Rothman N
    Lancet; 2005 Aug 20-26; 366(9486):649-59. PubMed ID: 16112301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Smoking and polymorphisms in xenobiotic metabolism and DNA repair genes are additive risk factors affecting bladder cancer in Northern Tunisia.
    Rouissi K; Ouerhani S; Hamrita B; Bougatef K; Marrakchi R; Cherif M; Ben Slama MR; Bouzouita M; Chebil M; Ben Ammar Elgaaied A
    Pathol Oncol Res; 2011 Dec; 17(4):879-86. PubMed ID: 21647780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-acetyltransferase 2 polymorphism and breast cancer risk with smoking: a case control study in Japanese women.
    Hara A; Taira N; Mizoo T; Nishiyama K; Nogami T; Iwamoto T; Motoki T; Shien T; Matsuoka J; Doihara H; Ishihara S; Kawai H; Kawasaki K; Ishibe Y; Ogasawara Y; Miyoshi S
    Breast Cancer; 2017 Mar; 24(2):254-262. PubMed ID: 27068825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymorphism of N-acetyltransferase 2 gene and the susceptibility to alcoholic liver cirrhosis: interaction with smoking.
    Yang KC; Huang YS; Perng CL; Lin HC; Lee SD
    Alcohol Clin Exp Res; 2011 Jul; 35(7):1204-8. PubMed ID: 21352246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
    Okkels H; Sigsgaard T; Wolf H; Autrup H
    Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytochrome P450 (CYP) 1A2, sulfotransferase (SULT) 1A1, and N-acetyltransferase (NAT) 2 polymorphisms and susceptibility to urothelial cancer.
    Tsukino H; Kuroda Y; Nakao H; Imai H; Inatomi H; Osada Y; Katoh T
    J Cancer Res Clin Oncol; 2004 Feb; 130(2):99-106. PubMed ID: 14648207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variation in N-acetyltransferase 2 (NAT2), smoking and risk of prostate cancer in the Slovak population.
    Vilčková M; Jurečeková J; Dobrota D; Habalová V; Klimčáková L; Waczulíková I; Slezák P; Kliment J; Sivoňová MK
    Med Oncol; 2014 Jun; 31(6):987. PubMed ID: 24816842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breast cancer, passive and active cigarette smoking and N-acetyltransferase 2 genotype.
    Delfino RJ; Smith C; West JG; Lin HJ; White E; Liao SY; Gim JS; Ma HL; Butler J; Anton-Culver H
    Pharmacogenetics; 2000 Jul; 10(5):461-9. PubMed ID: 10898115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A pilot study testing the genetic polymorphism of N-acetyltransferase 2 as a risk factor in lung cancer.
    Habalová V; Salagovic J; Kalina I; Stubna J
    Neoplasma; 2005; 52(5):364-8. PubMed ID: 16151580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-acetyltransferase NAT1 and NAT2 genotypes and lung cancer risk.
    Bouchardy C; Mitrunen K; Wikman H; Husgafvel-Pursiainen K; Dayer P; Benhamou S; Hirvonen A
    Pharmacogenetics; 1998 Aug; 8(4):291-8. PubMed ID: 9731715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymorphism of N-acetyltransferase 2 (NAT2) gene polymorphism in shanghai population: occupational and non-occupational bladder cancer patient groups.
    Ma QW; Lin GF; Chen JG; Xiang CQ; Guo WC; Golka K; Shen JH
    Biomed Environ Sci; 2004 Sep; 17(3):291-8. PubMed ID: 15602826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-acetyltransferase 2 (NAT2) genotypes, cigarette smoking, and the risk of breast cancer.
    Alberg AJ; Daudt A; Huang HY; Hoffman SC; Comstock GW; Helzlsouer KJ; Strickland PT; Bell DA
    Cancer Detect Prev; 2004; 28(3):187-93. PubMed ID: 15225898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NAT2 fast acetylator genotype is associated with an increased risk of lung cancer among never-smoking women in Taiwan.
    Chiou HL; Wu MF; Chien WP; Cheng YW; Wong RH; Chen CY; Lin TS; Lee H
    Cancer Lett; 2005 Jun; 223(1):93-101. PubMed ID: 15890241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NAT2 slow acetylation genotypes contribute to asthma risk among Caucasians: evidence from 946 cases and 1,091 controls.
    Wang Y; Zhang Q; Zhang M; Wang C
    Mol Biol Rep; 2014 Mar; 41(3):1849-55. PubMed ID: 24442317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GSTM1 and NAT2 polymorphisms and colon, lung and bladder cancer risk: a case-control study.
    Zupa A; Sgambato A; Bianchino G; Improta G; Grieco V; LA Torre G; Campisi B; Traficante A; Aieta M; Cittadini A
    Anticancer Res; 2009 May; 29(5):1709-14. PubMed ID: 19443391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colorectal adenomatous and hyperplastic polyps: smoking and N-acetyltransferase 2 polymorphisms.
    Potter JD; Bigler J; Fosdick L; Bostick RM; Kampman E; Chen C; Louis TA; Grambsch P
    Cancer Epidemiol Biomarkers Prev; 1999 Jan; 8(1):69-75. PubMed ID: 9950242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.